异动解读 | 同源康医药-B获H股全流通批准 盘中股价大涨5.24%

异动解读
20 Dec 2024

同源康医药-B(02410)今日盘中股价大涨5.24%,引起广泛关注。

消息面上,该公司获得中国证监会批准,将其持有的1.73亿股非上市股份转换为H股在港交所主板上市流通。这一举措提高了该股的流动性,为其股价上涨奠定了基础。

同源康医药-B获批H股全流通,反映了监管层对该公司的良性运营前景予以认可。通过增加可流通股份,将吸引更多资金进入,提振公司发展。在利好政策催化下,同源康医药-B今日盘中大涨5.24%,表现亮眼。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10